Former Sanofi chairman Nigel Brooksby has joined Pertinax Pharma as chairman. In addition to working his role at Sanofi he was chairman of the UK Life Sciences Strategy Board, where he secured a £32 million bid from the UK government for the continued expansion and development of skills for the life sciences sector. He is also a non-executive director at Porton Biopharma, a director of Stabilitech Pharma, a non-executive director at Chronos Therapeutics and chairman of Clinical Insights and Neurocentrx Pharma, as well as a past president of the ABPI.